Get a reply from this employer — a resume and cover letter tailored to exactly what they’re hiring for.
Our client is seeking a Medical Science Liaison, Oncology (Gyn-Onc) to act as the scientific bridge between the company and oncology thought leaders across a defined U.S. field territory.
The role involves leading in-depth scientific exchange with HCPs treating gynecologic and other malignancies and responding to medical inquiries. You will support the field medical strategy behind a newly launched, first-in-class oncology therapy and have a clear pathway toward senior MSL and field leadership
Our client is a well-established, publicly traded biopharmaceutical company that has spent more than two decades singularly focused on the science of a single hormonal signaling pathway, building a portfolio of more than 1,000 proprietary compounds along the way.
The company's newest FDA-approved therapy - its first entry into oncology - targets a defined hormone-receptor mechanism in a hard-to-treat gynecologic cancer, backed by practice-changing Phase 3 trial results published in a leading medical journal.
Candidates consistently point to the company's collaborative, data-driven culture and its rapid, well-funded growth as reasons to join.
As a Medical Science Liaison, you will serve as the scientific bridge between the company and oncology thought leaders across a defined U.S. field territory.
You’ll lead in-depth scientific exchange with HCPs treating gynecological and other malignancies, respond to medical inquiries, and support the field medical strategy behind a newly launched, first-in-class oncology therapy.
This is a ground-floor opportunity on a brand-new oncology franchise inside an already-profitable, publicly traded company - a combination of launch-stage energy and commercial stability that’s uncommon in MSL roles.
As the therapeutic area expands into additional tumor types, strong performers have a clear runway toward senior MSL and field leadership roles.
The ideal candidate will bring: